Table 7 Average costs and cost breakdown for the first year on antiretroviral therapy
Site 1 | Site 2 | Site 3 | Site 4 | Site 5 | Site 6 | All patients at all sitesd | |
|---|---|---|---|---|---|---|---|
Average cost, 2011 USD (95% CI) | |||||||
Average cost per patient for total sample | 151 (137–165) | 185 (168–202) | 166 (154–179) | 209 (192–225) | 251 (229–273) | 242 (224–260) | 198 (157–239) |
Average cost per patient for subset of sample retained in care one year after initiating ART | 184 (172–195) | 245 (235–254) | 205 (198–212) | 247 (233–261) | 304 (290–319) | 296 (285–307) | 243 (194–293) |
Breakdown of average cost per patient for subset of sample remaining in care one year after initiating ART, 2011 USD (% of total) | |||||||
ARV drugsa | 123 (67) | 166 (68) | 148 (72) | 207 (84) | 116 (38) | 178 (60) | 159 (66) |
Non-ARV drugsa | 12 (6) | 20 (8) | 4 (2) | 5 (2) | 0 (0) | 22 (7) | 11 (5) |
Laboratory tests | 11 (6) | 18 (7) | 27 (13) | 11 (5) | 49 (16) | 23 (8) | 22 (9) |
Clinic visitsb | 26 (14) | 27 (11) | 11 (5) | 17 (7) | 67 (22) | 33 (11) | 28 (11) |
Fixed resourcesc | 12 (6) | 14 (6) | 15 (7) | 7 (3) | 72 (24) | 39 (13) | 24 (9) |
Total | 184 (100) | 245 (100) | 205 (100) | 247 (100) | 304 (100) | 296 (100) | 243 (100) |